Redeye: Stille Q1 2023 - A solid start to the year
Redeye returns with an update on Stille following its Q1 2023 report. We have a largely positive take on the report, which slightly exceeded expectations in terms of sales. We moderately up our fair value range.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/